• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

RBC Transfusion

Costs of Type & Screen and Crossmatch Laboratory Tests for RBCs Higher in U.S. Compared to U.K.

Few studies have explored the cost of typing and matching RBCs for transfusions. To understand the cost of the ABO…

May 14, 2026

Donor, Storage, and Processing Characteristics Associated with Platelet Transfusion Outcomes

Platelet transfusions are critical to many patients such as those with thrombocytopenia, bleeding patients, and patients at risk of bleeding….

May 5, 2026

Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

β-thalassemia and sickle cell disease (SCD) are the most common monogenic diseases worldwide. About 20% of these patients may be…

April 28, 2026

Jehovah’s Witness Governing Body Allows Autologous Transfusions

Jehovah’s Witnesses (JWs) are a Christian denomination founded in the late 19th century in the United States with a focus…

April 23, 2026

RBC Exchange Transfusion for Patients with Severe Babesiosis

Babesiosis is a tick-borne disease primarily transmitted by the intraerythrocytic protozoa Babesia microti in the U.S., which causes malaria-like symptoms…

April 14, 2026

Intravenous Iron More Effective than Oral to Treat Anemia in Postpartum Women

  Although the prevalence of postpartum anemia is common—as high as 50% in high-income countries and 80% in low- and…

April 1, 2026

RBC Transfusions to Treat Acute Heavy Menstrual Bleeding

About one in four women of reproductive age experience uncomfortable and painful heavy menstrual bleeding. For some women, the pain…

January 7, 2026

RBC Transfusion Outcomes Similar in ICU Patients with and Without Cardiovascular Disease

In intensive care units (ICU), 25%-50% of patients receive RBC transfusions. Up to 30-40% of ICU patients also have a…

January 7, 2026

Phosphatidylserine and Phosphatidylethanolamine Levels on RBCs Important for Transfusion Outcomes

Phosphatidylserine (PS) and phosphatidylethanolamine (PE) are phospholipids that normally reside in the inner leaflet of the red blood cell membrane….

December 10, 2025

Liberal or Restrictive Transfusion Thresholds for Surgery Patients with High Cardiac Risk

Current RBC transfusion guidelines recommend a restrictive transfusion strategy for most patients, but ambiguity still remains for patients with high…

November 12, 2025

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 23
  • Go to Next Page »

Primary Sidebar

Latest News

  • Costs of Type & Screen and Crossmatch Laboratory Tests for RBCs Higher in U.S. Compared to U.K.

  • Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

  • Jehovah’s Witness Governing Body Allows Autologous Transfusions

  • RBC Exchange Transfusion for Patients with Severe Babesiosis

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley